Hypoxia alters phosphorylation status of insulin‐like growth factor (IGF)‐binding protein‐1 and attenuates biological activities of IGF‐I in HepG2 cell cultures
- 2 July 2013
- journal article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 39 (9), 1367-1373
- https://doi.org/10.1111/jog.12078
Abstract
Insulin-like growth factor (IGF)-I is known to stimulate fetal growth. One of the IGF-binding proteins, IGFBP-1, suppresses IGF-I activity, and thereby inhibits fetal growth. Because hypoxic stress in the uterus is known to cause fetal growth restriction, we examined the effects of hypoxia on IGFBP-1 production and phosphorylation status. Because liver is a main IGFBP-1 production site in the fetus, we used a hepatoma cell line, HepG2 cells, that secrete a large amount of IGFBP-1, express IGF-I receptors and model fetal liver metabolism in vitro. IGFBP-1 was analyzed by sodium dodecylsulfate polyacrylamide gel electrophoresis (PAGE) following immunoblotting, and IGFBP-1 phosphorylation status was analyzed by native PAGE following immunoblotting. Total concentrations of IGFBP-1 in media were higher and the highly phosphorylated isoforms were dominant in low oxygen conditions. Phosphorylation of IGF-I receptor by IGF-I was attenuated in low oxygen conditions. IGF-I-induced phosphorylation of insulin receptor substrate-1 (IRS-1) was attenuated in low oxygen conditions as well. However, attenuated phosphorylation of IGF-I receptor and IRS-1 were not observed in low oxygen conditions if the cells were stimulated with LR³IGF-I that has a similar binding affinity to IGF-I receptor but much less binding affinity to IGFBP-1 compared to those of native IGF-I. While IGF-I-induced cell proliferation was also inhibited in low oxygen conditions, LR³IGF-I-stimulated cell proliferation was not inhibited. These findings indicate that low oxygen conditions inhibit IGF-I action by increasing IGFBP-1, especially phosphorylated IGFBP-1, which inhibits IGF-I action. This study has indicated that hypoxia-induced IGFBP-1 production in the fetus may be a conserved physiological mechanism for restricting IGF-I-stimulated fetal growth.Keywords
This publication has 35 references indexed in Scilit:
- Hypoxia-Induced Intrauterine Growth Restriction Increases the Susceptibility of Rats to High-Fat Diet–Induced Metabolic SyndromeDiabetes, 2011
- Polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) potentiates IGF-I actions in placentaJournal of Cellular Physiology, 2010
- Insulin-like growth factor binding protein-1 induces decidualization of human endometrial stromal cells via 5 1 integrinMolecular Human Reproduction, 2008
- Leptin, insulin, insulin‐like growth factors and their binding proteins in cord serum: insight into fetal growth and discordancyClinical Endocrinology, 2006
- Posttranslational modifications of decidual IGFBP-1 by steroid hormones in vitroMolecular Human Reproduction, 2005
- Maternal Adaptation to High-altitude Pregnancy: An Experiment of Nature—A ReviewPlacenta, 2004
- COMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIESDrug Metabolism and Disposition, 2003
- Tissue Transglutaminase Facilitates the Polymerization of Insulin-like Growth Factor-binding Protein-1 (IGFBP-1) and Leads to Loss of IGFBP-1's Ability to Inhibit Insulin-like Growth Factor-I-stimulated Protein SynthesisOnline Journal of Public Health Informatics, 2001
- Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6)Progress in Growth Factor Research, 1991
- STUDIES OF INSULIN‐LIKE GROWTH FACTOR ‐I AND ‐II BY SPECIFIC RADIOLIGAND ASSAYS IN UMBILICAL CORD BLOODClinical Endocrinology, 1983